Abstract
Dynamic equilibrium between apoptosis and mitosis facilitates growth and development of the intestinal mucosa in mammalian neonates. Groups of enterocytes observed dying together on the villi in the gut of the neonates suggest involvement of the paracrine factors in the propagation of the death signalling. The most potent death-inducing, paracrine factor for the enterocytes is the TGF-β. It is secreted from the macrophages and epithelial cells upon uptake of apoptotic bodies. Through its receptor complex (TGF-R I and II) and SMAD cascade it regulates the intracellular balance of the pro- and antiapoptotic proteins from the Bcl-2 family, sensitising enterocytes for other death signals (i. e. TNFα) and directing them towards apoptosis. Just before and after birth mitosis-to-apoptosis ratio shifts towards proliferation. First ingestion of colostrum, initiates the major remodelling of the gut mucosa. Apoptosis is enhanced, facilitating the removal of foetal-type enterocytes and closing of the gut barrier. Second major remodelling stage occurs after weaning, when the adaptation to the ingestion of solid foods takes place. Proliferation and cell death in the intestinal mucosa are under the direct control of a variety of growth factors (EGF, IGFs, TGF-βs) and tissue hormones (leptin, ghrelin, GLP, CCK, etc.) provided either by mothers colostrum and milk or produced in the neonate organism. Finally, uncontrolled apoptosis may lead to the weakening of the gut barrier, which results in the increased susceptibility to the intestinal disorders, pathogen infiltration and may lead to the development of the necrotising enterocolitis in the infants.
Keywords: Apoptosis, autophagy, DNA damage, neonatal development, programmed cell death, small intestine development, intestinal mucosa, Enterocytes, Anoikis, TGF-beta family
Current Pediatric Reviews
Title: The Death Pathways in the Neonatal Gut
Volume: 7 Issue: 4
Author(s): Michal M. Godlewski
Affiliation:
Keywords: Apoptosis, autophagy, DNA damage, neonatal development, programmed cell death, small intestine development, intestinal mucosa, Enterocytes, Anoikis, TGF-beta family
Abstract: Dynamic equilibrium between apoptosis and mitosis facilitates growth and development of the intestinal mucosa in mammalian neonates. Groups of enterocytes observed dying together on the villi in the gut of the neonates suggest involvement of the paracrine factors in the propagation of the death signalling. The most potent death-inducing, paracrine factor for the enterocytes is the TGF-β. It is secreted from the macrophages and epithelial cells upon uptake of apoptotic bodies. Through its receptor complex (TGF-R I and II) and SMAD cascade it regulates the intracellular balance of the pro- and antiapoptotic proteins from the Bcl-2 family, sensitising enterocytes for other death signals (i. e. TNFα) and directing them towards apoptosis. Just before and after birth mitosis-to-apoptosis ratio shifts towards proliferation. First ingestion of colostrum, initiates the major remodelling of the gut mucosa. Apoptosis is enhanced, facilitating the removal of foetal-type enterocytes and closing of the gut barrier. Second major remodelling stage occurs after weaning, when the adaptation to the ingestion of solid foods takes place. Proliferation and cell death in the intestinal mucosa are under the direct control of a variety of growth factors (EGF, IGFs, TGF-βs) and tissue hormones (leptin, ghrelin, GLP, CCK, etc.) provided either by mothers colostrum and milk or produced in the neonate organism. Finally, uncontrolled apoptosis may lead to the weakening of the gut barrier, which results in the increased susceptibility to the intestinal disorders, pathogen infiltration and may lead to the development of the necrotising enterocolitis in the infants.
Export Options
About this article
Cite this article as:
M. Godlewski Michal, The Death Pathways in the Neonatal Gut, Current Pediatric Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339611796892256
DOI https://dx.doi.org/10.2174/157339611796892256 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunotherapy in Breast Cancer- Paving New Roads?
Current Molecular Pharmacology Recent Design and Structure-Activity Relationship Studies on the Modifications of DHFR Inhibitors as Anticancer Agents
Current Medicinal Chemistry Profilin1 Sensitizes Pancreatic Cancer Cells to Irradiation by Inducing Apoptosis and Reducing Autophagy
Current Molecular Medicine Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis
Current Neuropharmacology Endothelin-1 and Angiogenesis in Cancer
Current Vascular Pharmacology Association Between miR-146a rs2910164 Polymorphism and Breast Cancer Susceptibility: An Updated Meta-Analysis of 9545 Cases and 10030 Controls
MicroRNA Novel N-Substituted Thiazolidinones as Proton Pump Inhibitors and Potent Anti-Ulcer Agents: SAR Study
Letters in Drug Design & Discovery Studies of p53 Tumor Suppression Activity in Mouse Models
Current Genomics Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
Current Topics in Medicinal Chemistry Array-Based Approaches for the Identification of Epigenetic Silenced Tumor Suppressor Genes
Current Genomics Mediterranean Diet and Oxidation: Nuts and Olive Oil as Important Sources of Fat and Antioxidants
Current Topics in Medicinal Chemistry Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry Nanomaterial Based Affinity Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for Biomolecules and Pathogenic Bacteria
Recent Patents on Nanotechnology Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Drug Target Identification for Neuronal Apoptosis Through a Genome Scale Screening
Current Medicinal Chemistry Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions
Current Alzheimer Research Modern Drug Discovery Technologies: Opportunities and Challenges in Lead Discovery
Combinatorial Chemistry & High Throughput Screening Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Current Enzyme Inhibition Mitochondria and Familial Predisposition to Breast Cancer
Current Genomics Recent Development in Applications of Important Biopolymer Chitosan in Biomedicine, Pharmaceuticals and Personal Care Products
Current Tissue Engineering (Discontinued)